Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sudinnova

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 10
Rounds per year 0.28
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Exits 5
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Medical
  • Health Care
  • Medical Device
  • Robotics
Summary

Sudinnova appeared to be the VC, which was created in 1983. The venture was found in Europe in France. The main department of described VC is located in the Lyon.

The high activity for fund was in 2013. The top amount of exits for fund were in 2016. The usual things for fund are deals in the range of 1 - 5 millions dollars. Comparing to the other companies, this Sudinnova performs on 9 percentage points more the average number of lead investments. The fund is constantly included in less than 2 deals per year.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Sudinnova, startups are often financed by Aster, Sodero Gestion, Sociu00e9tu00e9 Financiu00e8re Lorient Du00e9veloppementis. The meaningful sponsors for the fund in investment in the same round are CM-CIC Innovation, Banque de Vizille, Octalfa. In the next rounds fund is usually obtained by Aster, CM-CIC Innovation, ODYSSEE VENTURE.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Groupe Adeuza, Kerlink, Polyplus-transfection. The fund has no exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical, Telecommunications.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sudinnova:
Typical Co-investors
Sudinnova is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sudinnova:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Africa Business Conference at Harvard Business School Boston, Massachusetts, United States
Archipelago Next Las Palmas, Las Palmas de Gran Canaria, Spain
Bonduelle France, Provence-Alpes-Cote d'Azur, Villeneuve
Chisholm Private Capital Partners Oklahoma, Oklahoma City, United States
Corecam Family Office Switzerland, Zürich, Zurich
Dazhong Ziben China, Shanghai
ECI Telecom HaMerkaz, Israel, Petah Tikwah
Equipo Ventures California, San Francisco, United States
Eurovestech England, London, United Kingdom
Funika Holding Denizli, Denizli, Turkey
General Electric Pension Trust Austin, Texas, United States
Huafu Securities Co., Ltd. China, Foochow, Fujian
Jinhaisheng Chuangtou -
Lingdu Capital China, Hubei, Wuhan
Perea Capital -
Power Energy Eagle Creek -
Scitex Herzliya, Israel, Tel Aviv
Shire Capital Advisors -
Telescope Investment Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

e(ye)BRAIN

Biotechnology
Medical
Medical Device
$3M09 Oct 2012 France, Ile-de-France, France

Endocontrol

Health Care
Medical
Medical Device
Robotics
$3M01 Jan 2010 France, Auvergne-Rhône-Alpes, France

Endocontrol

Health Care
Medical
Medical Device
Robotics
$1M01 Dec 2007 France, Auvergne-Rhône-Alpes, France

Interview

Software
$1M11 Jul 2007 France, Auvergne-Rhône-Alpes, France

Software
$910K26 Sep 2005 Nantes, Pays de la Loire

Software
$1M05 Aug 2005 France, Ile-de-France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sudinnova?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 1M
Rounds per year 0.28
Peak activity year 2013
Lead investments 0
Follow on index 0.09
Exits 5
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

e(ye)BRAIN

Biotechnology
Medical
Medical Device
$3M09 Oct 2012 France, Ile-de-France, France

Endocontrol

Health Care
Medical
Medical Device
Robotics
$3M01 Jan 2010 France, Auvergne-Rhône-Alpes, France

Endocontrol

Health Care
Medical
Medical Device
Robotics
$1M01 Dec 2007 France, Auvergne-Rhône-Alpes, France

Interview

Software
$1M11 Jul 2007 France, Auvergne-Rhône-Alpes, France

Software
$910K26 Sep 2005 Nantes, Pays de la Loire

Software
$1M05 Aug 2005 France, Ile-de-France
Crunchbase icon

Content report

The following text will be sent to our editors: